“MOLECULAR DOCKING STUDY OF QUINOLIN-4(1H)-ONE DERIVATIVES AS VEGFR-2 INHIBITORS FOR THE TREATMENT OF LUNG CANCER”. Frontier in Medical and Health Research 3, no. 6 (August 1, 2025): 1–15. Accessed March 9, 2026. https://fmhr.net/index.php/fmhr/article/view/712.